Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
C4 Therapeutics, Inc
NASDAQ:CCCC
C4 Therapeutics, Inc
NASDAQ:CCCC
Price:
3.21
USD
Market Cap:
$394.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C4 Therapeutics, Inc
NASDAQ:CCCC
|
US |
|
C
|
China Everbright Ltd
F:EVI
|
HK |
|
CIMB Group Holdings Bhd
OTC:CIMDF
|
MY |
|
T
|
Tripadvisor Inc
F:T6A
|
US |
|
C
|
Corporate Travel Management Ltd
F:1C6
|
AU |
|
Tripadvisor Inc
NASDAQ:TRIP
|
US |
|
I
|
Integrated Rail and Resources Acquisition Corp
F:5A3
|
US |
|
H
|
HA Sustainable Infrastructure Capital Inc
F:6HA
|
US |
|
E
|
Edel SE & Co KgaA
XMUN:EDL
|
DE |
|
T
|
Tripadvisor Inc
XMUN:T6A
|
US |
|
P
|
Public Storage
F:PUP
|
US |
|
P
|
PICC Property and Casualty Co Ltd
XMUN:PJC
|
CN |
|
A
|
Aptargroup Inc
F:AGT
|
US |
|
BAB Inc
OTC:BABB
|
US |
|
S
|
Shake Shack Inc
F:9SH
|
US |
|
La Francaise de l Energie SA
F:LFX
|
FR |
|
Calumet Inc
NASDAQ:CLMT
|
US |
|
P
|
PICC Property and Casualty Co Ltd
F:PJC
|
CN |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
BMV:BBVA
|
ES |
|
A
|
Alba Mineral Resources PLC
F:9AB
|
UK |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
B
|
Bilfinger Se
XHAN:GBF
|
DE |
|
P
|
Prada SpA
XMUN:PRP
|
IT |
|
L
|
Land Securities Group PLC
F:LSU2
|
UK |
Wall St Price Targets
CCCC Price Forecast
Based on 10 analysts
Based on 10 analysts
+234% Upside
from
$3.21
today
C4 Therapeutics, Inc (CCCC)’s 12-month stock price forecast through November 2027 has a consensus target of $10.71, implying 234% upside. The forecast is based on price targets from 10 Wall Street analysts.
CCCC Analyst Rating
Based on 9 analysts
Based on 9 analysts
Analysts rate CCCC Strong buy, with 9 of 9 recommending Buy or Strong buy.
C4 Therapeutics, Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CCCC's stock price target?
Price Target
10.71
USD
10.71
USD
According to Wall Street analysts, the average 1-year price target for CCCC is 10.71 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for C4 Therapeutics, Inc?
Projected CAGR
47%
47%
Over the last 6 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 47%.
